Crossmark

A need for clinical trial: re-purposing the Monoamine Oxidase Inhibitors (MAO-I) for rheumatoid arthritis (RA)

Published Online: 2023-08-09

Published Print: 2023-12

Authors

Bala, Asis https://orcid.org/0000-0002-2148-2331
License Information

Text and Data Mining valid from 2023-08-09

Version of Record valid from 2023-08-09
More Information

Article History

Received: 6 July 2023

Accepted: 27 July 2023

First Online: 9 August 2023

Declarations

:

: The author does not have any relevant financial or non-financial interests to disclose.

: Not applicable.

Document is current